Legend Capital

Legend Capital, established in 2001, is a Beijing-based venture capital firm and subsidiary of Legend Holdings Ltd. It manages multiple funds totaling up to US$700 million, focusing on early-stage IT companies and mid-market growth stage companies in China. Its investment sectors include network applications and services, outsourcing, professional services, IC design, key components, consumer goods, clean technology, healthcare, and modern services. Legend Capital actively supports its portfolio companies, providing business resources and tailored services to facilitate growth and enhance returns. Notable portfolio companies include Joyo.com (acquired by Amazon.com) and Spreadtrum Communications (Nasdaq: SPRD).

Daqing Cai

Managing Director

Hao Chen

Managing Director and Head of Investment

Raymond CHEN

Co-Chief Investment Officer

Rui Chen

Managing Director

Frank Hong

Managing Director

Henry Ji

Executive Director

Yi Kang

Director

Richard Li

President

Jiaqing Li

Managing Director

Joon Sung Park

Executive Director

FAN Qihui

Executive Director

Jenking Shao

Managing Director and Partner

Zhenxing Shao

Partner / Managing Director

Jeff Wang

Managing Director

Junfeng Wang

Managing Director

Nengguang Wang

Managing Director and CFO

Piau-Voon Wang

COO

Tony WANG

VP

Ge Xinyu

Managing Director

Quan Zhou

Managing Director, Partner

Hank Zhou

Executive Director

Hongbin Zhou

Managing Director

Linan Zhu

Chairman

William Wen

Executive Director

Past deals in Series B

AiCheng Technology

Series B in 2025
Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.

Volant Aerotech

Series B in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.

Hohem

Series B in 2024
Hohem is a camera gimbal developer specialized in the research, development, and design of drone flight control and image stabilization systems. Its key products are automatic face tracking shooting stabilizer, Bat vision positioning multi-rotor flight control system, Bfly multi-rotor flight control system, and Bee cross-country multi-rotor flight control system.

Nuwacell

Series B in 2024
Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.

Macrolux Medical

Series B in 2024
MacroLux is a medical technology company that specializes in endoscopic interventional solutions for diagnosis and treatment. The company focuses on developing devices that enhance the detection and treatment of conditions in urology, respiratory, and digestive health. By offering advanced endoscopic therapies, MacroLux aims to improve patient outcomes through earlier diagnosis and more effective treatment options, catering to a wide range of medical customers.

Angitia Biopharmaceuticals

Series B in 2023
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.

Saige Research

Series B in 2023
Saige Research is a company that focuses on providing artificial intelligence solutions specifically for the manufacturing sector, particularly in the area of industrial inspection and quality control. The firm has developed a deep learning vision inspection platform that addresses the challenges faced by inspectors, enhancing work efficiency. This technology offers capabilities such as power detection, speed detection, and versatility, allowing for greater convenience in development. By automating the inspection process, Saige Research aims to deliver optimal AI solutions that improve quality assurance in manufacturing environments.

Zhipu AI

Series B in 2023
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

HC Scientific

Series B in 2023
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.

Tailan New Energy

Series B in 2023
Tailan New Energy is a company dedicated to the research and development of innovative energy technologies, specifically new solid-state lithium batteries and essential lithium battery materials. Co-founded by experts in lithium battery research and a seasoned industrialization team, it aims to advance the technology and commercialization of these batteries. The company also focuses on electronic special materials and resource recycling, offering a range of services that includes battery sales, battery leasing, and the sale of graphite and carbon products. Through its efforts, Tailan New Energy seeks to contribute to the evolving landscape of energy storage solutions.

Open Source China

Series B in 2023
Open Source China is a prominent community focused on open source technology, providing a platform for IT developers to discover, utilize, and exchange open source software. The community offers various resources, including open source software libraries, code sharing, discussion forums, and collaborative translation services. It serves as a hub for technical support, allowing users to seek answers to software-related questions and access relevant information. By fostering collaboration and knowledge sharing, Open Source China promotes the development and application of open source technologies among domestic developers, enhancing their ability to innovate and improve these technologies.

DentaFilm

Series B in 2023
DentaFilm is a provider of oral intelligent equipment and a full-chain platform (FICP), concentrating on the advancement of both digital cloud platforms and oral intelligent equipment. It focuses on oral equipment for data collection, data storage, data transmission, data management, and data applications, covering clinic 2D, and 3D image data, CAD/ CAM design, clinic ERP system, PMS, equipment IoT intelligent management.

Rongke Power

Series B in 2023
Rongke Power specializes in the development and manufacture of vanadium redox flow batteries, focusing on safe and reliable energy storage solutions. The company offers a variety of products, including container energy storage systems and comprehensive energy storage solutions, as well as operation and maintenance services for power stations. By providing these innovative energy storage products, Rongke Power aims to support enterprises in creating cleaner and more energy-efficient energy grids. Additionally, the company has established itself as an independent provider of intellectual property rights related to its battery technologies.

Shuhai Supply Chain

Series B in 2022
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.

APTBIO

Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.

RUICYCLE

Series B in 2022
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company specializes in developing solutions for lithium battery recovery, encompassing cascade utilization, material regeneration, and new material recycling. RUICYCLE's innovative technologies offer industry users a closed-loop ecosystem that emphasizes automatic safe crushing and environmentally friendly treatment processes. By focusing on zero pollution and efficient recycling, RUICYCLE aims to address the challenges associated with lithium battery waste and contribute to sustainable practices in the industry.

Joymed Technology

Series B in 2022
Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.

Lipinyun

Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.

ZHIYI TECH

Series B in 2022
Zhiyi Tech develops a supply chain platform for intelligent clothing design. They offer services for digitalized trend forecasting, design selection, and supply chain organization. They provide clothing companies with core functions such as fashion trend prediction, design empowerment, and style recommendation, and expand to the downstream of the industrial chain via the SaaS portal, providing one-stop design and flexible production supply chain platform services.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technologies creates artificial intelligence chips that may be reconfigured to improve energy efficiency. The company's chips are designed with low power consumption, intelligent speech and visual features in mind, providing customers with a better consumer electronics experience and application.

MediLink Therapeutics

Series B in 2022
MediLink Therapeutics is a biotechnology company based in Suzhou, China, specializing in the development of next-generation antibody-drug conjugates (ADCs). The company aims to address significant unmet medical needs in China by creating innovative therapeutics that target cancer while minimizing damage to healthy cells. MediLink Therapeutics is committed to enhancing patient outcomes through its research and development efforts, which include conducting multicenter clinical trials and engaging in cross-border collaborations to generate global value. By focusing on ADCs, the company strives to improve the efficacy of cancer treatments while ensuring patient safety during therapy.

Inceptio Technology

Series B in 2022
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.

Zhipu AI

Series B in 2022
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Singlomics

Series B in 2022
Singlomics is a biotechnology company that specializes in single-cell sequencing technology to facilitate antibody drug development aimed at treating infectious diseases and cancers. The company has made significant advancements in antibody discovery, having developed neutralizing antibodies such as DXP593 and DXP604, which offer potential solutions in the fight against COVID-19. By leveraging its innovative technology, Singlomics focuses on creating targeted therapies that address critical health challenges.

Beijing Tianxing

Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.

Xbiome

Series B in 2021
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

ColorTech Bio

Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

Jifan Biotechnology

Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

LePure Biotech

Series B in 2021
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples in biosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad.

Wuxi Biortus Biosciences

Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, specializing in research and development services that support drug discovery. Founded in 2009, the company offers a range of services, including recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus Biosciences is recognized for its commitment to quality and innovation, having established five advanced research platforms that enhance its capabilities in drug development. The company’s R&D team has developed various innovative techniques, some of which have been patented, further solidifying its role in the biotechnology sector. It operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.

ForQaly

Series B in 2021
ForQaly specializes in the development of minimally invasive ventricular assist devices designed to treat heart failure patients. The company focuses on creating therapeutic devices that enhance circulation while ensuring affordability for patients. Their products are characterized by features such as reduced trauma, high auxiliary flow, and user-friendly design, providing healthcare professionals with effective solutions for improving patient health. By combining innovation with accessibility, ForQaly aims to address the clinical needs of patients suffering from heart conditions.

HC Scientific

Series B in 2021
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Berry Oncology

Series B in 2021
Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.

YEASEN Biotechnology

Series B in 2021
Yeasen is a biotechnology company that provides molecular enzymes, proteins, antibodies, nucleic acids, and cells. They produce fields of life science research, diagnosis and detection, and biomedicine.

Bloks Technology Group

Series B in 2021
Bloks Group uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bloks Group strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.

Dearer Medical

Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.

Fiture Technology

Series B in 2021
Fiture is a fitness technology company focused on transforming home fitness through innovative hardware and artificial intelligence. The company offers customized online workout courses alongside the manufacturing of intelligent home workout equipment. By leveraging AI technologies, Fiture aims to enhance user experience and support clients in achieving healthier lifestyles through effective at-home fitness solutions.

Stonewise

Series B in 2021
StoneWise is a technology company established in 2018 that focuses on enhancing the drug discovery process through artificial intelligence. The company aims to transform traditional drug research and development by implementing a dual-engine model that combines advanced AI technology with expert systems. Its platform utilizes cutting-edge technologies, including microfluidics, computational chemistry, computational biology, pharmacology, and clinical medicine, to offer integrated solutions for pharmaceutical companies. These solutions encompass a variety of tools, such as medical knowledge graphs, molecular generation and design, and predictions of reaction products and synthetic pathways. By leveraging this innovative platform, StoneWise seeks to improve the efficiency and success rates of early-stage drug discoveries. The company collaborates with both domestic and international experts in various scientific fields, and maintains a state-of-the-art facility to stay abreast of the latest advancements in drug discovery.

Sciwind Biosciences

Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company specializing in the development and sale of protein and peptide drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company focuses on therapeutic areas such as diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neuro-degenerative conditions. Sciwind's innovative drug candidates are particularly targeted at metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for healthcare professionals and their patients.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Jinqirui Biology

Series B in 2020
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Xbiome

Series B in 2020
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

Aqrose Technology

Series B in 2020
Aqrose Technology Co., Ltd., founded in 2017 from the AI Lab of Tsinghua University, specializes in the application of advanced artificial intelligence and machine vision technologies in industrial settings. The company provides a range of products, including its standardized intelligent industrial vision platform AIDI and the AIPICK intelligent inspecting and sorting robot, which utilize 3D vision technology for automation. Aqrose's solutions support various sectors such as consumer electronics, automotive, new energy, pharmaceuticals, semiconductors, and logistics, enhancing manufacturing processes and product quality. With deployments in over 100 factories, including leading enterprises in advanced manufacturing and smart logistics, Aqrose is committed to empowering its clients through innovative technology.

Hemu (China) Biological Engineering

Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

HEMO BIOENGINEERING

Series B in 2020
HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.

Leadrive

Series B in 2020
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.

Haihe Biopharma

Series B in 2020
Haihe Biopharma is dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors. By focusing on these advancements, Haihe Biopharma seeks to enhance health outcomes for patients and improve the quality of research in the pharmaceutical field.

ESWIN Computing

Series B in 2020
ESWIN Computing specializes in the research and development of RISC-V computing architecture, focusing on the design and testing of integrated circuits for Internet of Things (IoT) applications. The company develops chips used in display devices and wearable technology, providing comprehensive solutions in areas such as artificial intelligence, human-computer interaction, and the Internet of Vehicles. By combining innovative design with advanced materials, ESWIN Computing aims to enhance user experiences across various digital platforms.

Uditech

Series B in 2020
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.

iBeiDiao

Series B in 2020
iBeiDiao is an intelligent employee background investigation service-providing company. They provide objective background-checking services and employee onboarding management solutions for employees using artificial intelligence, providing employee credit reference information for enterprises.

Wangdiantong

Series B in 2020
Wangdiantong ERP is a provider of enterprise-level e-commerce solutions that facilitate the integration of online and offline retail operations. The company's services encompass a range of functionalities, including inventory management, order processing, purchasing, after-sales service, and customer relationship management. By supporting major platforms such as Taobao, Tmall, Jingdong, Amazon, and Alibaba, Wangdiantong enables businesses to effectively manage multi-warehouse systems and streamline operations for both online stores and physical retail locations. Additionally, the company offers intelligent warehouse solutions and cloud-based services designed to assist enterprises in transitioning to digital management and scaling their operations efficiently.

Healing Paper

Series B in 2020
Healing Paper operates a platform focused on enhancing access to cosmetic surgery services while promoting transparency and affordability. The company utilizes information and communication technology to provide patients with estimates for necessary procedures, honest reviews, and special pricing options. In addition to connecting patients with cosmetic treatment options, Healing Paper fosters a real-time community for sharing experiences and offers management tools for post-surgery care. By balancing information between medical professionals and patients, Healing Paper aims to improve the quality of cosmetic beauty services and make them more accessible.

ANYCOLOR

Post in 2020
ANYCOLOR is an entertainment startup that specializes in supporting and managing the Nijisanji Project, which features virtual talents known as VTubers. The company focuses on creator support and licensing, enabling the operation of virtual talents to engage audiences worldwide. By leveraging advanced technology, ANYCOLOR aims to provide innovative experiences that enrich daily life and reflect contemporary societal themes. Through its commitment to the VTuber phenomenon and other emerging projects, the company seeks to shape the future of digital entertainment.

Harbour BioMed

Series B in 2020
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Genskey

Series B in 2020
GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.

Nanovision

Series B in 2019
Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base with an additional subsidiary in Chengdu, specializes in high-speed and high-precision radiology imaging. The company focuses on the development of static CT, X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision created China's first self-developed CMOS flat panel detector, known as the Merak series. Its products are applicable in various sectors, including medical, industrial, and security, offering advanced technological support both domestically and internationally. With a significant research and development foundation, Nanovision is positioned as a key player in the radiation imaging industry.

RT-Thread

Series B in 2019
RT-Thread is a Shanghai-based company established in 2006 that specializes in developing an open-source real-time operating system (RTOS) for embedded devices. The RTOS is designed for a wide range of applications, particularly in the Internet of Things (IoT) sector, offering features such as cross-chip compatibility, cloud integration, ultra-low power consumption, and security. The system includes a device virtual file system, a device manager framework, low-power management, and firmware update capabilities. RT-Thread supports both resource-constrained microcontroller systems with its Nano version, which requires minimal memory, and more resource-rich IoT devices, allowing for modular customization through user-friendly tools. The company serves various industries, including new energy, home appliances, and transportation, providing a stable and scalable platform that facilitates easy access to major IoT cloud services.

Xbiome

Series B in 2019
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

Gambol Pet Group

Series B in 2019
Gambol Pet Group Co., Ltd is a pet food manufacturer based in Liaocheng City, China, founded in 2006. The company specializes in a diverse range of products, including dry and wet pet food, real meat jerky treats, rawhide chews, and dental bones, catering to both dogs and cats. Its product lineup features various categories such as pet treats made from chicken, duck, pork, lamb, and fish, as well as wet food incorporating meat, fruits, and vegetables. Gambol Pet Group is committed to research and development, ensuring that its offerings include nutritional supplements and natural ingredients. The company distributes its products across Europe, Asia, and North America, serving a wide customer base. Under the leadership of Chairman and CEO Qin Hua, Gambol Pet Group continues to expand its presence in the pet food industry.

dMed

Series B in 2019
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.

QANDA(Mathpresso)

Series B in 2019
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.

GalaxySpace

Series B in 2019
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.

AgotoZ

Series B in 2019
AgotoZ Technology, established in 2017 as Guanmai Technology (Beijing) Co., Ltd., specializes in providing high-speed network transmission services tailored for enterprises. The company focuses on WAN high-speed transmission core technology, big data computing, and security defense solutions. By leveraging its capabilities in resource calculation and security, AgotoZ aims to enhance the efficiency and interoperability of enterprise networks. Through independent research and development, it offers advanced technologies and products designed to meet the evolving needs of businesses seeking reliable and efficient network transmission solutions.

Tongcheng Shenghuo

Series B in 2019
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Inossem

Series B in 2019
Inossem is a technology company dedicated to aiding organizations in their digital transformation efforts, with a primary focus on enhancing operational efficiency and fostering business growth. Headquartered in Montreal, Quebec, Inossem Canada operates as a subsidiary and provides consulting services across the country, specializing in research and development for enterprise applications. Its offerings include corporate advisory services, digital supply chain solutions, and digital workforce tools. The digital supply chain segment features products like InStock, an intelligent storage solution, and InData, which focuses on master data management, both leveraging AI and IoT technologies. Additionally, Inossem's supply chain optimization product, InoVAT, aims to enhance warehouse and inventory management capabilities. In the realm of digital workforce solutions, ProcessGo facilitates rapid data and process integration through automation, providing clients with streamlined operational capabilities. Through its innovative products and services, Inossem supports organizations in achieving sustainable growth by leveraging industry-specific insights and global digital practices.

Shuhai Supply Chain

Series B in 2019
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.

Jiangrongxin Technology

Series B in 2019
Jiangrongxin Technology specializes in developing financial and marketing software tailored for consumer financial services enterprises. The company offers a credit card core system designed to assist card issuers in managing cardholder credit and incentives effectively. Additionally, Jiangrongxin Technology provides a marketing platform that facilitates purchase recommendations to consumers and enables the tracking of user retention, thereby enhancing customer engagement and loyalty.

River Security

Series B in 2019
River Security specializes in advanced cybersecurity solutions, focusing on fraud risk protection and dynamic application security. Established in 2012 with headquarters in Shanghai, Beijing, and Shenzhen, the company has developed innovative technologies that enhance the security of corporate website applications and safeguard business data. Its dynamic security bot-gate product utilizes a unique approach to predict server behavior by transforming the underlying code of web pages, allowing for more efficient and timely defenses against various modern cyber attacks. This technology represents a significant departure from traditional security methods, enabling businesses to reduce deployment and operational costs while improving overall security effectiveness.

Black Sesame Technologies

Series B in 2019
Black Sesame Technologies is an AI digital imaging technology firm founded in 2016, with locations in Silicon Valley and Shanghai. The company specializes in developing solutions for real-world AI challenges, focusing on image processing, computing images, and embedded sensing platforms. It provides advanced algorithms for applications in smartphones, autonomous driving, and various consumer electronics. The firm conducts extensive research and development, including core algorithm development, ASIC design, and software systems for advanced driver-assistance systems (ADAS). Black Sesame Technologies is committed to innovation, quality, and reliable service, leveraging the extensive industry experience of its team members. The company has designed automotive-grade system-on-chips (SoCs), including the high-computing Huashan Series and the cross-domain Wudang Series, aimed at enhancing intelligent vehicle solutions and driving the future of mobility.

Likechuxing

Series B in 2019
Likechuxing is a car-sharing travel service platform designed for urban travelers, leveraging the sharing economy to transform traditional car travel. By integrating mobile Internet technology with a time-sharing model, the platform allows users to conveniently access vehicles located within 500 meters. This innovative approach caters specifically to the needs of short-haul travel within cities, enabling users to manage their car rental experience through a mobile app. The app facilitates intelligent operation throughout the entire process, allowing users to pay only for the mileage and long-term costs associated with their journeys. Likechuxing effectively redefines the car rental experience, making urban mobility more efficient and accessible.

Tenry Pharmaceutical

Series B in 2019
Shanghai Tenry Pharmaceutical Company Limited operates two advanced manufacturing facilities in Shanghai, specializing in the production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company is recognized as a technology-driven enterprise, focusing on the development and commercialization of innovative healthcare solutions. Tenry holds 73 nationally approved drugs and two biological agents, with its primary products aimed at bleeding and wound management. Through its commitment to research and development, along with regulatory compliance, Tenry strives to enhance patient care by providing effective treatment options.

Harbour BioMed

Series B in 2018
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Urotronic

Series B in 2018
Urotronic, Inc. is a medical device company based in Plymouth, Minnesota, that specializes in developing innovative solutions for urology. Founded in 2014, the company focuses on its flagship product, Optilume, a drug-coated balloon (DCB) catheter designed to treat urethral strictures in men. This minimally invasive device combines balloon dilation with localized drug delivery, utilizing paclitaxel to prevent the recurrence of strictures by limiting cell proliferation and fibrotic scar tissue formation. Urotronic aims to provide urologists and patients with a cost-effective alternative to traditional treatment methods, improving outcomes for individuals suffering from urinary tract conditions.

Spacety

Series B in 2018
Spacety, established in 2016 and headquartered in Changsha, China, is a microsatellite company specializing in developing and launching commercial micro and nano-satellites. It offers rapid, cost-effective, and comprehensive services to scientists, research institutions, and businesses for scientific experiments and technology demonstrations. As of now, Spacety has successfully launched four commercial microsatellites, with plans for more in the future.

Lunit

Series B in 2018
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Aikucun

Series B in 2018
Aikucun is a sales distribution company that provides fast and controllable inventory sales channels. As the micro-business purchasing channels have a certain privacy, completely independent of the traditional sales channels, and will not affect the brand's existing sales system. The brand owner can easily complete the inventory sales simply by sharing the inventory. Founded in 2017 by Shanghai Zhongdan Information Technology Co., Ltd., Aikucun is a crowdsourcing distribution platform.

Renderbus

Series B in 2018
Renderbus provides vertical cloud computing SaaS services for the vision industry.

Paixue Che

Series B in 2018
Pai Xueche is an Internet driving training platform. The school adopts a consultant tracking system throughout the process. The company will equip each student with an exclusive learning car consultant, from registration to the student's driver's license, the whole process of tracking.

Enjoy Dental Clinic

Series B in 2018
Enjoy Dental Clinic is a prominent dental care provider based in Beijing, China, established in 2007. It operates as a large-scale dental chain that integrates medical treatment, scientific research, education, and administrative functions. The clinic adheres to standardized practices in oral health treatment, employing advanced techniques such as 3D printing, digital-guided dental implants, and oral digital CT scanning. Additionally, Enjoy Dental Clinic prioritizes aseptic procedures and individualized care, utilizing a "one person, one machine" approach to ensure safety and hygiene. The clinic also offers franchising services, facilitating dental training and clinic development for aspiring dentists, thereby contributing to the growth of dental care expertise in the region.

Nattitude

Series B in 2018
Nattitude is a retailer focused on developing and selling amino acid-based personal care products aimed at Chinese families. The company offers a range of high-quality and affordable items, including shampoos, cleansing mousses, and shower gels. Nattitude's commitment to natural ingredients is reflected in its product line, which includes subscription-based brands like Zhiguan. The company has secured investments through both angel and A rounds within its first year, highlighting its potential for growth in the consumer products market.

Uditech

Series B in 2018
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.

DeepWise

Series B in 2018
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.

INXX

Series B in 2018
INXX operates an online retail platform that serves as a hub for local and international fashion brands, with a particular emphasis on high-end professional sportswear. The platform is designed to cater to fashion leaders and artists, providing them access to a diverse range of fashionable clothing and accessories. By bringing together artists, designers, and creators from various fields, INXX promotes street-wear culture in China, enabling consumers to discover and purchase high-quality fashion products efficiently. The company aims to create a trendy environment that fosters collaboration and innovation within the fashion industry.

Kunya Medical

Series B in 2018
Kunya Medical is a provider of medical equipment management services focused on enhancing the maintenance and operational efficiency of hospital equipment. The company offers comprehensive services, including the maintenance and hosting of hospital imaging and radiation equipment, as well as installation, debugging, and repair of large and medium-sized medical devices. Kunya Medical also supplies spare parts and management software, facilitating improved oversight and longevity of clinical medical equipment for hospitals. By outsourcing these critical functions, Kunya Medical aims to help healthcare facilities optimize their equipment management and extend the lifecycle of their medical assets.

iPayLinks

Series B in 2018
iPayLinks is a prominent provider of cross-border settlement services based in Lujiazui, Shanghai, with branches in various countries including the UK, US, UAE, and India. The company serves over 50,000 institutions and enterprises, offering a comprehensive "three-in-one" cross-border settlement solution tailored for e-commerce and travel sectors. Its platform supports a wide range of international payment methods, including major credit cards and localized options in more than 200 regions. iPayLinks also facilitates payment collection from platforms such as Amazon and eBay, alongside providing supply chain finance solutions that enhance working capital turnover. The company holds various international licenses and has achieved PCI-DSS Level-1 certification, a highly regarded standard in the payment industry. iPayLinks has garnered recognition through several awards and has attracted funding from notable investors, reflecting its strong position in the fintech landscape.

Hongliyu Cinema

Series B in 2018
Hongliyu Cinema is a rural cinema operator based in China, specializing in the management and operation of local theaters. The company provides services related to cinema investment, operation management, and professional training, aiming to enhance the efficiency of theater operations and improve digital media services. Additionally, Hongliyu Cinema is involved in film and television production as well as advertising operation services, contributing to the development of the local cinema landscape.

Taihe Music Group

Series B in 2017
Taihe Music Group is a global music service provider and record label producer that provides artist services, copyright management, audio-visual services and live performance.

Yanwen Express

Series B in 2017
Beijing Yanwen Logistics Co., Ltd, established in 1998 and headquartered in Beijing, China, is a specialized logistics company providing freight forwarding and logistics services. The company focuses on serving e-commerce businesses by offering tailored international logistics solutions. Yanwen is equipped to handle a wide range of shipments, from small packages to larger goods, utilizing various modes of transportation including aircraft, trains, and automobiles. The firm emphasizes professional transport management to meet the diverse needs of its customers, supported by approvals from relevant government departments.

Immunochina

Series B in 2017
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

WeShine

Series B in 2017
WeShine is a Chinese platform specializing in the sharing of GIF images and video content. The service has reached over 800 million users across China, establishing a significant presence in the market with a reported market share of over 90% in the GIF search engine sector. WeShine offers a user-friendly interface that enables individuals to easily search for and share popular visual content, making it a prominent player in the digital media landscape.

Qian Qian Music

Series B in 2017
Qian Qian Music is an online music platform.

Vingoo Juice

Series B in 2017
Vingoo Juice specializes in creating autonomous machines designed for producing fresh orange juice, primarily targeting the community market in China. By employing a "whole fruit extraction" method, these machines maximize juice yield from each orange, providing customers with enhanced value. The company integrates advanced technologies such as cloud computing, artificial intelligence, and mobile payment systems to elevate the consumer experience, making the process of obtaining fresh juice both intuitive and efficient.

Bellen

Series B in 2017
Bellen Chemistry is a premier provider of a variety of heterocycles. Our activity is focused on the design and development of novel molecules,6361413375267061158256368.jpgintermediates for the Chemical and Pharmaceutical industries. Bellen Chemistryhas a strong R&D team with a talent pool of 200+ trained scientists. We have excellent track records, as we deliver unrivalled chemical innovation to our customers worldwide.

Ucpaas

Series B in 2017
Ucpaas is a provider of cloud communication services based in Shenzhen, China, focused on developing an open platform for converged communication solutions. The company offers a comprehensive cloud computing platform that integrates the capabilities of major telecommunications operators and Internet networks. By utilizing open REST APIs and client SDKs for various operating systems, Ucpaas enables developers and businesses to easily implement voice, SMS, VoIP, and video communication solutions without the burden of hardware or network costs. With over a decade of experience in the VoIP communications industry, Ucpaas has amassed a large user base and holds a significant share of telecommunications resources. The company's specialized team, composed of members with extensive backgrounds in telecommunications and technology, drives innovation and product development, ensuring that Ucpaas remains a competitive player in the digital communication landscape.

New Horizon Health

Series B in 2017
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

Akulaku

Series B in 2017
Akulaku Inc. is a prominent banking and digital finance platform headquartered in Jakarta, Indonesia, founded in 2016. It operates across Southeast Asia, including Indonesia, the Philippines, and Malaysia, focusing on meeting the financial needs of underserved customers in emerging markets. The company provides a variety of services, including digital banking, financing, investment, and insurance brokerage. Its offerings feature a virtual credit card, an e-commerce platform, and Asetku, an online wealth management service. Additionally, Akulaku has launched Neobank, a mobile digital bank supported by Bank Neo Commerce. The company aims to serve 50 million users in Southeast Asia by 2025, facilitating a range of financial transactions, from mobile top-ups to installment shopping, thereby enhancing the shopping experience for its users.

PhiSkin

Series B in 2017
PhiSkin is a skin and laser clinic based in China, specializing in aesthetic medicine. The clinic offers a range of services, including aesthetic product injections such as Botox and hyaluronic acid, laser treatments, and non-surgical beauty procedures like double eyelid surgery. PhiSkin aims to provide customers with a comprehensive understanding of their skin conditions, along with tailored skincare solutions to meet individual needs.

Bangsun Technology

Series B in 2017
Bangsun Technology, based in Hangzhou, China, specializes in developing online payment security software tailored for domestic internet trading companies and financial institutions. Founded in 2010, the company offers a range of solutions, including banking and tripartite payment solutions, as well as services for bank cards, credit cards, and securities. Its product lineup features real-time transaction anti-fraud systems, Internet credit services, data analytics through machine learning, device fingerprinting, and anti-money laundering solutions. Additionally, Bangsun Technology focuses on providing comprehensive risk management services, including application anti-fraud measures and robot defense, to enhance the security of financial transactions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.